Literature DB >> 8701849

Increased plasma levels of B-type natriuretic peptide in patients with unstable angina.

K Kikuta1, H Yasue, M Yoshimura, E Morita, H Sumida, H Kato, K Kugiyama, H Ogawa, K Okumura, Y Ogawa, K Nakao.   

Abstract

This study was designed to examine the plasma levels of B-type or brain natriuretic peptide (BNP), as well as A-type or atrial natriuretic peptide (ANP) in patients with unstable angina as compared with those in patients with stable exertional angina and control subjects. We measured the plasma levels of BNP and ANP in 33 patients with unstable angina, 20 patients with stable exertional angina, and 20 control subjects. The plasma levels of BNP were significantly increased in patients with unstable angina compared with those in patients with stable exertional angina and control subjects, respectively (39.5 +/- 29.4 pg/ml vs 15.1 +/- 8.0 pg/ml; p < 0.01 and 39.5 +/- 29.4 pg/ml vs 10.3 +/- 6.4 pg/ml; p < 0.01, respectively). On the other hand, there was no significant difference in the plasma levels of ANP among the three groups. Furthermore, in patients with unstable angina, the plasma levels of BNP decreased significantly after the medical treatment (from 39.5 +/- 29.4 pg/ml to 15.8 +/- 11.0 pg/ ml; p < 0.01), whereas the plasma levels of ANP did not change. We conclude that the plasma levels of BNP are increased in the majority of patients with unstable angina and that the increased levels decrease toward normal after treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8701849     DOI: 10.1016/s0002-8703(96)90396-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

Review 1.  Best evidence topic report. Brain natriuretic peptide as a potential marker of acute coronary syndromes.

Authors:  Richard Body; Catherine Roberts
Journal:  Emerg Med J       Date:  2006-05       Impact factor: 2.740

2.  Effects of lesion complexity on baseline and postprocedural B-type natriuretic peptide levels in patients undergoing percutaneous coronary interventions.

Authors:  Aylin Yildirir; Sadik Acikel; Cagatay Ertan; Alp Aydinalp; Bulent Ozin; Haldun Muderrisoglu
Journal:  Tex Heart Inst J       Date:  2007

3.  Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina.

Authors:  S Talwar; I B Squire; P F Downie; J E Davies; L L Ng
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

Review 4.  Brain natriuretic peptide and optimal management of heart failure.

Authors:  Nan Li; Jian-An Wang
Journal:  J Zhejiang Univ Sci B       Date:  2005-09       Impact factor: 3.066

5.  Changes in N-terminal pro B-type natriuretic peptide concentration: comparative study of percutaneous transluminal coronary angioplasty and off-pump coronary artery bypass graft.

Authors:  Hyun Koo Kim; Hark Jei Kim; Jin Won Kim; Young-sang Sohn; Young Ho Choi
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

Review 6.  Natriuretic peptide hormone measurement in acute coronary syndromes.

Authors:  Param Maewal; James A de Lemos
Journal:  Heart Fail Rev       Date:  2003-10       Impact factor: 4.214

7.  Endothelial permeability in vitro and in vivo: protective actions of ANP and omapatrilat in experimental atherosclerosis.

Authors:  Tomoko Ichiki; Ririko Izumi; Alessandro Cataliotti; Amy M Larsen; Sharon M Sandberg; John C Burnett
Journal:  Peptides       Date:  2013-08-06       Impact factor: 3.750

8.  Plasma ProBNP Is Not a Specific Marker for Transient Myocardial Ischemia.

Authors:  Khawar Maqsood; Muhammad T Shakoor; James R Cook; Gregory R Giugliano; Amir Lotfi
Journal:  J Clin Med Res       Date:  2015-05-08

9.  B-type natriuretic peptide release and left ventricular filling pressure assessed by echocardiographic study after subarachnoid hemorrhage: a prospective study in non-cardiac patients.

Authors:  Eric Meaudre; Christophe Jego; Nadia Kenane; Ambroise Montcriol; Henry Boret; Philippe Goutorbe; Gilbert Habib; Bruno Palmier
Journal:  Crit Care       Date:  2009-05-20       Impact factor: 9.097

10.  Biomarkers in Acute Coronary Syndrome.

Authors:  Valentina Loria; Milena Leo; Gina Biasillo; Ilaria Dato; Luigi M Biasucci
Journal:  Biomark Insights       Date:  2008-11-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.